IL95061A0 - Antagonists of gm-csf derived from the carboxyl terminus - Google Patents

Antagonists of gm-csf derived from the carboxyl terminus

Info

Publication number
IL95061A0
IL95061A0 IL95061A IL9506190A IL95061A0 IL 95061 A0 IL95061 A0 IL 95061A0 IL 95061 A IL95061 A IL 95061A IL 9506190 A IL9506190 A IL 9506190A IL 95061 A0 IL95061 A0 IL 95061A0
Authority
IL
Israel
Prior art keywords
antagonists
carboxyl terminus
csf derived
csf
derived
Prior art date
Application number
IL95061A
Other languages
English (en)
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of IL95061A0 publication Critical patent/IL95061A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/243—Colony Stimulating Factors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/53—Colony-stimulating factor [CSF]
    • C07K14/535—Granulocyte CSF; Granulocyte-macrophage CSF
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Toxicology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
IL95061A 1989-07-14 1990-07-12 Antagonists of gm-csf derived from the carboxyl terminus IL95061A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US37984689A 1989-07-14 1989-07-14

Publications (1)

Publication Number Publication Date
IL95061A0 true IL95061A0 (en) 1991-06-10

Family

ID=23498958

Family Applications (1)

Application Number Title Priority Date Filing Date
IL95061A IL95061A0 (en) 1989-07-14 1990-07-12 Antagonists of gm-csf derived from the carboxyl terminus

Country Status (16)

Country Link
US (1) US5475087A (fr)
EP (2) EP0482086A1 (fr)
JP (1) JPH04503815A (fr)
KR (1) KR920701246A (fr)
AU (1) AU630496B2 (fr)
CA (1) CA2062975A1 (fr)
FI (1) FI920150A0 (fr)
HU (1) HUT63181A (fr)
IE (1) IE902562A1 (fr)
IL (1) IL95061A0 (fr)
MY (1) MY105946A (fr)
NO (1) NO920176L (fr)
NZ (1) NZ234479A (fr)
PH (1) PH27534A (fr)
WO (1) WO1991001330A1 (fr)
ZA (1) ZA905480B (fr)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2060741A1 (fr) * 1991-02-11 1992-08-12 Robert S. Greenfield Oligopeptides inhibant le gm-csf
AU5611394A (en) * 1992-11-19 1994-06-08 Dana-Farber Cancer Institute Antibodies for gm-csf receptor and uses thereof
DK96493D0 (da) * 1993-08-26 1993-08-26 Mouritsen Og Elsner Aps Fremgangsmaade til at inducere antistofresponser mod selvproteiner og autovaccine fremstillet ved fremgangsmaaden
FR2730154B1 (fr) * 1995-02-08 1997-07-11 Stephanois Rech Dispositif de mesure des efforts exerces lors de la marche
AUPN378095A0 (en) * 1995-06-23 1995-07-20 Bresagen Limited Haemopoietic growth factor antagonists and uses therefor
US8062637B2 (en) * 2000-05-08 2011-11-22 Morphosys Ag Methods of ameliorating inflammatory disease using an uPA antagonist
US7455836B2 (en) * 2000-05-08 2008-11-25 The University Of Melbourne Method of treatment and agents useful for same
US7247618B2 (en) * 2001-04-30 2007-07-24 Tripathi Rajavashisth Methods for inhibiting macrophage colony stimulating factor and c-FMS-dependent cell signaling
AR045563A1 (es) 2003-09-10 2005-11-02 Warner Lambert Co Anticuerpos dirigidos a m-csf
EP1712241A1 (fr) 2005-04-15 2006-10-18 Centre National De La Recherche Scientifique (Cnrs) Composition pour application intratumorale dans le traitement du cancer
AU2005100402B4 (en) * 2005-05-16 2006-01-12 Novomatic Ag Method for increased chances at an award on a Gaming Machine
US7741450B2 (en) 2006-02-08 2010-06-22 Morphotek Inc. Antibodies to GM-CSF
AU2013201228B2 (en) * 2006-02-08 2016-01-21 Eisai, Inc. Antigenic gm-csf peptides and antibodies to gm-csf
US8398972B2 (en) 2006-11-21 2013-03-19 Kalobios Pharmaceuticals, Inc. Methods of treating dementia using a GM-CSF antagonist
EP2101780B1 (fr) * 2006-11-21 2013-10-09 Kalobios Pharmaceuticals, Inc. Procédés de traitement des maladies inflammatoires chroniques à l'aide d'un antagoniste du gm-csf
TW200918553A (en) * 2007-09-18 2009-05-01 Amgen Inc Human GM-CSF antigen binding proteins
CN104072613A (zh) 2007-11-13 2014-10-01 Evec股份有限公司 与hGM-CSF结合的单克隆抗体及包含它的药物组合物
CN102271705A (zh) 2008-12-22 2011-12-07 墨尔本大学 骨关节炎治疗
CA2747206C (fr) 2008-12-22 2018-04-24 The University Of Melbourne Traitement de la douleur
WO2013026059A1 (fr) 2011-08-18 2013-02-21 New York University Inhibition de la production et de la fonction de gm-csf induit par kras oncogène
CA2856329A1 (fr) * 2011-11-17 2013-05-23 Glia Sp Z.O.O. Compositions et methodes de traitement du gliome
EP4291380A1 (fr) 2021-02-15 2023-12-20 Splifar S.A. Procédé d'application d'un joint d'étanchéité sur une plaque
CN119144565B (zh) * 2023-11-24 2025-11-25 成都赛恩吉诺生物科技有限公司 表达GM-CSF的exon 2功能区的免疫工程细胞及应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI83662C (fi) * 1980-07-17 1991-08-12 Scripps Clinic Res Diagnostik antikropp och foerfarande foer dess framstaellning.
UA39161C2 (uk) * 1984-07-06 2001-06-15 Новартіс Аг Рекомбінантний білок gm-csf для збільшення продукції гранулоцитів і макрофагів у пацієнтів, вектор і кднк, що його кодують
AU588819B2 (en) * 1984-10-29 1989-09-28 Immunex Corporation Cloning of human granulocyte-macrophage colony stimulating factor gene

Also Published As

Publication number Publication date
EP0482086A1 (fr) 1992-04-29
IE902562A1 (en) 1991-02-27
NO920176D0 (no) 1992-01-14
FI920150A7 (fi) 1992-01-14
FI920150A0 (fi) 1992-01-14
ZA905480B (en) 1991-03-27
KR920701246A (ko) 1992-08-11
US5475087A (en) 1995-12-12
HUT63181A (en) 1993-07-28
HU9200087D0 (en) 1992-04-28
AU630496B2 (en) 1992-10-29
MY105946A (en) 1995-02-28
JPH04503815A (ja) 1992-07-09
CA2062975A1 (fr) 1991-01-15
PH27534A (en) 1993-08-18
WO1991001330A1 (fr) 1991-02-07
NZ234479A (en) 1992-03-26
AU6148790A (en) 1991-02-22
EP0409091A1 (fr) 1991-01-23
NO920176L (no) 1992-01-14

Similar Documents

Publication Publication Date Title
IL95061A0 (en) Antagonists of gm-csf derived from the carboxyl terminus
IL65211A0 (en) Polypeptide antagonists arginine vasopressin
PH21284A (en) Gnrh antagonists vi
IL96475A0 (en) Chimeric proteins
AU569060B2 (en) Gnrh antagonists
AU2535284A (en) Leukotriene antagonists
GB8925298D0 (en) Object tracking
AU4662885A (en) cDNA probe for the detection of bluetongue virus
JPS6466174A (en) Leukotriene antagonist
EP0418863A3 (en) Nmda antagonists
GB8924829D0 (en) Object tracking
ZA84912B (en) Gnrh antagonists
AU1619288A (en) Vasopressin antagonists
GB8925211D0 (en) Improved impedance bond
GB9022784D0 (en) Sonobuoy location
ZA905205B (en) Theunis christiaan verster the location of objects
IE871656L (en) Leukotriene antagonists
IE872915L (en) Leukotriene antagonists
GB8907660D0 (en) Polypeptide
IE852104L (en) GnRH ANTAGONISTS VI
IE894106L (en) Expression of the plasmodium circumsporozite protein in¹insects
GB8908765D0 (en) The knocker bell
ZA907310B (en) Nmda antagonists
IE871356L (en) Polypeptide compositions
CS691488A1 (en) Connection for metallic structures' potential measuring